TABLE 5.
E. faecium reference strains and Tx16 antigen antisera reactivity
| Strain | Source | Date | MLST STa | VRE? | Ref. | MFI ratio (immune/preimmune sera) |
Leg IGCF orthologues? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Pf1 | Pf2 | Pf3 | Pf4 | |||||||
| E0155 | Fecal (hospital) | 1995 | 17 (17) | Yes | 26 | 2 | 30 | 6 | 106 | Yes |
| E0980 | Fecal (community) | 1998 | 94 | 45 | 3 | 25 | 8 | 100 | Yes | |
| E1039 | Fecal (community) | 1998 | 42 | 45 | 1 | 1 | 11 | 2 | ||
| E1071 | Fecal (hospital) | 2000 | 32 | Yes | 45 | 2 | 2 | 16 | 5 | |
| E1162 | Clinical (blood) | 1997 | 17 (17) | 45 | 2 | 1 | 7 | 3 | ||
| E1636 | Clinical (blood) | 1961 | 106 | 45 | 1 | 1 | 6 | 1 | ||
| E1679 | Clinical (catheter) | 1998 | 114 | Yes | 45 | 2 | 1 | 13 | 1 | |
| U0317 | Clinical (urine) | 2005 | 78 (78) | 45 | 2 | 6 | 11 | 5 | Yes | |
| 1,231,502 | Clinical (blood) | 2005 | 203 (78) | Yes | 44 | 3 | 14 | 21 | 45 | Yes |
| 1,231,410 | Clinical (SSTI) | 2005 | 17 (17) | Yes | 44 | 3 | 8 | 21 | 11 | Yes |
| 1,230,933 | Clinical (blood) | 2005 | 18 (18) | Yes | 44 | 3 | 5 | 21 | 11 | Yes |
| 1,231,501 | Clinical (blood) | 2005 | 52 | 44 | 2 | 1 | 8 | 1 | ||
| 1,231,408 | Clinical (blood) | 2005 | 582 | 44 | 3 | 1 | 26 | 1 | ||
| 1,141,733 | Clinical (wound) | 2005 | 52 | 44 | 2 | 1 | 2 | 1 | ||
| Com12 | Fecal (community) | 2006 | 107 | 44 | 2 | 1 | 6 | 1 | ||
| Com15 | Fecal (community) | 2006 | 583 | 44 | 2 | 1 | 3 | 1 | ||
| Tx16 | Clinical (blood) | 1992 | 18 (18) | 22 | 3 | 19 | 11 | 13 | Yes | |
| Tx1330 | Fecal (community) | 1994 | 107 | 22 | 2 | 1 | 6 | 1 | ||
| E. faecalis FA2-2 | JH2 (plasmid-cured) | ≤1973 | 8 | 46 | 1 | 1 | 6 | 1 | ||
a Hospital-associated lineage is indicated in parentheses (24).